Zacks Investment Research
07 Jul 2026, 12:41 UTC · 13w ago
Impact · against what's priced in
The recent price spike in Profound Medical is driven by technical momentum and general sentiment rather than new fundamental catalysts. While projected revenue growth is strong, the widening quarterly losses and stagnant earnings estimates suggest the move lacks a sustainable fundamental driver.
No priced-in read yet
What the story claims
4 claims · scored −1 bearish … +1 bullish
Profound Medical (PROF) shares rose 8.2% in the last session on elevated trading volume.
More positive than 66% of claims this week
Profound Medical's revenues are expected to grow 153.4% year-over-year to $5.6 million in the upcoming report.
Continue reading
5 related stories
The 8.2% price increase is attributed to momentum buying and general sentiment regarding commercial execution rather than company-specific news, though the company expects significant revenue growth of 153.4% to $5.6 million.
Read from the article alone
Scored by the NIS engine · methodology.
More positive than 54% of claims this week
Profound Medical is expected to report a quarterly loss of $0.22 per share, a 57.7% increase in losses year-over-year.
More negative than 69% of claims this week
The consensus EPS estimate for Profound Medical has remained unchanged over the last 30 days.
More negative than 63% of claims this week
Which stocks this story touches
More positive than 76% of ticker scores this week
Shares soared 8.2% due to momentum buying and strong sentiment regarding commercial execution and clinical progress.
More positive than 52% of ticker scores this week
Stock closed 1.5% higher with a modest 2.9% gain over the past month.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Zacks Investment Research
1h ago
−5.1%
Price is moving against the score
$6.99 vs $7.37 close before publication (Jul 6) · not market-adjusted
PROF chart →
